Stephanie(Heon)CardarellaMD

Oncology • South Weymouth, MA

Instructor in Medicine, Dana-Farber Cancer Institute

Join to view full profile

Dr. Cardarella is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cardarella's full profile

Already have an account?

Office
55 Fogg Rd
South Weymouth, MA 02190
Phone+1 781-624-8000

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2007 - 2011
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2004 - 2007
McGill University Faculty of MedicineClass of 2004

Certifications & Licensure

MA State Medical License 2006 - 2025
RI State Medical License 2013 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

43 citations
Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.
Mizuki Nishino, Suzanne E. Dahlberg, Stephanie Cardarella, David M. Jackman, Michael S. Rabin
Journal of Thoracic Oncology. 2013-08-01
27 citations
Cost-Effectiveness of Multiplexed Predictive Biomarker Screening in Non-Small-Cell Lung Cancer
Dorothy Romanus, Stephanie Cardarella, David M. Cutler, Mary Beth Landrum, Neal I. Lindeman
Journal of Thoracic Oncology. 2015-04-01
30 citations
RECIST 1.1 in NSCLC Patients With EGFR Mutations Treated With EGFR Tyrosine Kinase Inhibitors: Comparison With RECIST 1.0
Mizuki Nishino, Stephanie Cardarella, David M. Jackman, Nikhil H. Ramaiya, Michael S. Rabin
AJR. American Journal of Roentgenology. 2013-06-21

Other Languages

French